CAS 934660-93-2 appears in our catalog under these names: [3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl][3-hydroxy-3-(2S)-2-piperidinyl-1-azetidinyl]methanone, 98%, 98%, Cobimetinib, XL518, >95% (HPLC), Cobimetinib/ 99.98% (existing batch purity), Cobimetinib 98%. Offered by: Chemat, Chemat Brand, TRC, TargetMol, GLPBio. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 250mg, on request.
Cobimetinib is a member of the class of N-acylazetidines obtained by selective formal condensation of the carboxy group of 3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid with the secondary amino group from the azetidine ring of 3-[(2S)-piperidin-2-yl]azetidin-3-ol. An inhibitor of mitogen-activated protein kinase that is used (as its fumarate salt) in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma. It has a role as an antineoplastic agent and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of piperidines, a tertiary alcohol, an aromatic amine, an organoiodine compound, a difluorobenzene, a N-acylazetidine and a secondary amino compound. It is a conjugate base of a cobimetinib(1+).
Source: ChEBI
| Molecular formula | C21H21F3IN3O2 |
|---|---|
| Molecular weight | 531.3 g/mol |
| IUPAC name | [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone |
| InChIKey | BSMCAPRUBJMWDF-KRWDZBQOSA-N |
| SMILES | C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O |
Computed by PubChem (NCBI)